Soluble HLA peptidome: A new resource for cancer biomarkers by Erwin Tanuwidjaya, Ralf B. Schittenhelm, Pouya Faridi, Pouya Faridi

Subjects: Get full text

Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy by Anna Reustle, Moreno Di Marco, Carolin Meyerhoff, Annika Nelde, Juliane S. Walz, Stefan Winter, Siahei Kandabarau, Florian Büttner, Mathias Haag, Linus Backert, Daniel J. Kowalewski, Steffen Rausch, Jörg Hennenlotter, Viktoria Stühler, Marcus Scharpf, Falko Fend, Arnulf Stenzl, Hans-Georg Rammensee, Jens Bedke, Stefan Stevanović, Matthias Schwab, Elke Schaeffeler

Subjects: Get full text

CD74 regulates complexity of tumor cell HLA class II peptidome in brain metastasis and is a positive prognostic marker for patient survival by P. S. Zeiner, J. Zinke, D. J. Kowalewski, S. Bernatz, J. Tichy, M. W. Ronellenfitsch, F. Thorsen, A. Berger, M. T. Forster, A. Muller, J. P. Steinbach, R. Beschorner, J. Wischhusen, H. M. Kvasnicka, K. H. Plate, S. Stefanović, B. Weide, M. Mittelbronn, P. N. Harter

Subjects: Get full text

Identification of HLA-A*11:01 and A*02:01-Restricted EBV Peptides Using HLA Peptidomics by Yufei Wang, Wanlin Zhang, Ruona Shi, Yanran Luo, Zhenhuan Feng, Yanhong Chen, Qiuting Zhang, Yan Zhou, Jingtong Liang, Xiaoping Ye, Qisheng Feng, Xiaofei Zhang, Miao Xu

Subjects: Get full text

Unsupervised Mining of HLA-I Peptidomes Reveals New Binding Motifs and Potential False Positives in the Community Database by Chatchapon Sricharoensuk, Tanupat Boonchalermvichien, Phijitra Muanwien, Poorichaya Somparn, Trairak Pisitkun, Trairak Pisitkun, Sira Sriswasdi, Sira Sriswasdi

Subjects: Get full text